// App-Quantinova.ai

AB1272 : ONLINE EDUCATION BOOSTS CLINICIAN KNOWLEDGE ABOUT EMERGING THERAPIES FOR PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE

Researchers

Presenter

  • C. Rohani-Montez

Principal Investigators

  • M. Calle

  • C. Allen

  • A. M. Hoffmann-Vold

  • O. Distler

Medical Centers

  • Medscape Education Global, London, United Kingdom

  • IQVIA, New York, United States of america

  • Oslo University Hospital, Oslo, Norway

  • University Hospital of Zurich, Zurich, Switzerland

Locations

  • United Kingdom

  • United States

  • Norway

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Autoimmune (AI)

Disease

  • Interstitial lung disease

  • Scleroderma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Boehringer Ingelheim

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved